- Home
- NRSN vs SNAL Comparison
NRSN vs SNAL Comparison
Compare NRSN & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRSN | SNAL |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | Israel | United States |
| Employees | 15 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4M | 29.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | NRSN | SNAL |
|---|---|---|
| Price | $0.82 | $0.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 167.6K | 19.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 120.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $84,467,047.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $50.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 38.69 |
| 52 Week Low | $0.68 | $0.56 |
| 52 Week High | $2.60 | $2.15 |
Technical Indicators
Market Signals| Indicator | NRSN | SNAL |
|---|---|---|
| Relative Strength Index (RSI) | 40.95 | 45.42 |
| Support Level | $0.68 | $0.58 |
| Resistance Level | $1.30 | $0.71 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 19.62 | 29.59 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.